Health SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – TIG, QUMU, HZNP, PSBP January 4, 2023
Biotechnology Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference January 4, 2023
Biotechnology BioMarin to Present at 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, at 10:30 am PT /1:30 pm ET, in San Francisco, CA January 4, 2023